Skip to main content
Top
Published in: Journal of Cancer Education 1/2017

01-03-2017

Barriers and Strategies to Participation in Tissue Research Among African-American Men

Authors: Bettina F. Drake, Danielle Boyd, Kimberly Carter, Sarah Gehlert, Vetta Sanders Thompson

Published in: Journal of Cancer Education | Issue 1/2017

Login to get access

Abstract

Before the burgeoning field of biospecimen collection can advance prevention and treatment methods, researchers must access diverse molecular data samples. However, minorities, especially African-American men, remain reticent to join these studies. This study, using theory-based approaches, investigated African-American men’s barriers to participating in biorepository research. Fourteen focus groups were conducted among 70 African-American men (ages 40 to 80). The groups were stratified by prostate cancer history and educational attainment background. Participants identified perceived factors that promoted or hindered study participation when questioned about their knowledge and attitudes about biospecimen research. Ninety-four percent of participants indicated never participating in a study that collected biological samples. Barriers to their participation included lack of knowledge and understanding regarding biospecimen research practices and uses. In addition, they extensively cited a prevalent mistrust of the medical community and discomfort with study recruitment practices. African-American males were more willing to participate in biorepository studies with physician endorsement or if they understood that participation could benefit future generations. Men also wanted more recruitment and advertising done in familiar places.
Literature
1.
go back to reference National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services: National Cancer Institute Best Practices for Biospecimen Resources. . In.; 2007 National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services: National Cancer Institute Best Practices for Biospecimen Resources. . In.; 2007
2.
go back to reference Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M (2003) Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 97(6):1499–1506CrossRefPubMed Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M (2003) Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 97(6):1499–1506CrossRefPubMed
3.
go back to reference Halbert CH, Weathers B, Delmoor E, Mahler B, Coyne J, Thompson HS, Have TT, Vaughn D, Malkowicz SB, Lee D (2009) Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 115(11):2553–2561CrossRefPubMedPubMedCentral Halbert CH, Weathers B, Delmoor E, Mahler B, Coyne J, Thompson HS, Have TT, Vaughn D, Malkowicz SB, Lee D (2009) Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 115(11):2553–2561CrossRefPubMedPubMedCentral
4.
go back to reference Moinpour CM, Atkinson JO, Thomas SM, Underwood SM, Harvey C, Parzuchowski J, Lovato LC, Ryan AM, Hill MS, Deantoni E et al (2000) Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 10(8 Suppl):S85–91CrossRefPubMed Moinpour CM, Atkinson JO, Thomas SM, Underwood SM, Harvey C, Parzuchowski J, Lovato LC, Ryan AM, Hill MS, Deantoni E et al (2000) Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 10(8 Suppl):S85–91CrossRefPubMed
5.
go back to reference Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS (2000) Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21(6 Suppl):379S–389SCrossRefPubMed Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS (2000) Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21(6 Suppl):379S–389SCrossRefPubMed
6.
go back to reference Shavers VL, Lynch CF, Burmeister LF (2002) Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 12(4):248–256CrossRefPubMed Shavers VL, Lynch CF, Burmeister LF (2002) Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 12(4):248–256CrossRefPubMed
7.
8.
go back to reference Kiviniemi MT, Saad-Harfouche FG, Ciupak GL, Davis W, Moysich K, Hargrave NC, Ambrosone CB, Walker C, Erwin DO (2013) Pilot intervention outcomes of an educational program for biospecimen research participation. J Cancer Educ 28(1):52–59CrossRefPubMedPubMedCentral Kiviniemi MT, Saad-Harfouche FG, Ciupak GL, Davis W, Moysich K, Hargrave NC, Ambrosone CB, Walker C, Erwin DO (2013) Pilot intervention outcomes of an educational program for biospecimen research participation. J Cancer Educ 28(1):52–59CrossRefPubMedPubMedCentral
9.
go back to reference Dash C, Wallington SF, Muthra S, Dodson E, Mandelblatt J, Adams-Campbell LL (2014) Disparities in knowledge and willingness to donate research biospecimens: a mixed-methods study in an underserved urban community. J Commun Genet 5(4):329–336CrossRef Dash C, Wallington SF, Muthra S, Dodson E, Mandelblatt J, Adams-Campbell LL (2014) Disparities in knowledge and willingness to donate research biospecimens: a mixed-methods study in an underserved urban community. J Commun Genet 5(4):329–336CrossRef
10.
go back to reference Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, Gooding R, DeWitty RL (2004) Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol 22(4):730–734CrossRefPubMed Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, Gooding R, DeWitty RL (2004) Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol 22(4):730–734CrossRefPubMed
11.
go back to reference Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed
12.
go back to reference Thompson VL, Drake B, James AS, Norfolk M, Goodman M, Ashford L, Jackson S, Witherspoon M, Brewster M, Colditz G: A community coalition to address cancer disparities: transitions, successes and challenges. J Cancer Educ 2014 Thompson VL, Drake B, James AS, Norfolk M, Goodman M, Ashford L, Jackson S, Witherspoon M, Brewster M, Colditz G: A community coalition to address cancer disparities: transitions, successes and challenges. J Cancer Educ 2014
13.
go back to reference Swanson GM, Ward AJ (1995) Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 87(23):1747–1759CrossRefPubMed Swanson GM, Ward AJ (1995) Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 87(23):1747–1759CrossRefPubMed
14.
go back to reference Melas PA, Sjoholm LK, Forsner T, Edhborg M, Juth N, Forsell Y, Lavebratt C (2010) Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study. J Med Ethics 36(2):93–98CrossRefPubMed Melas PA, Sjoholm LK, Forsner T, Edhborg M, Juth N, Forsell Y, Lavebratt C (2010) Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study. J Med Ethics 36(2):93–98CrossRefPubMed
15.
go back to reference Levickis P, Naughton G, Gerner B, Gibbons K (2013) Why families choose not to participate in research: feedback from non-responders. J Paediatr Child Health 49(1):57–62CrossRefPubMed Levickis P, Naughton G, Gerner B, Gibbons K (2013) Why families choose not to participate in research: feedback from non-responders. J Paediatr Child Health 49(1):57–62CrossRefPubMed
16.
go back to reference Streicher SA, Sanderson SC, Jabs EW, Diefenbach M, Smirnoff M, Peter I, Horowitz CR, Brenner B, Richardson LD (2011) Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Commun Genet 2(3):153–163CrossRef Streicher SA, Sanderson SC, Jabs EW, Diefenbach M, Smirnoff M, Peter I, Horowitz CR, Brenner B, Richardson LD (2011) Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Commun Genet 2(3):153–163CrossRef
17.
go back to reference Halverson CM, Ross LF (2012) Attitudes of African-American parents about biobank participation and return of results for themselves and their children. J Med Ethics 38(9):561–566CrossRefPubMedPubMedCentral Halverson CM, Ross LF (2012) Attitudes of African-American parents about biobank participation and return of results for themselves and their children. J Med Ethics 38(9):561–566CrossRefPubMedPubMedCentral
18.
go back to reference Bussey-Jones J, Garrett J, Henderson G, Moloney M, Blumenthal C, Corbie-Smith G (2010) The role of race and trust in tissue/blood donation for genetic research. Genet Med 12(2):116–121CrossRefPubMedPubMedCentral Bussey-Jones J, Garrett J, Henderson G, Moloney M, Blumenthal C, Corbie-Smith G (2010) The role of race and trust in tissue/blood donation for genetic research. Genet Med 12(2):116–121CrossRefPubMedPubMedCentral
19.
go back to reference Masters JR (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2(4):315–319CrossRefPubMed Masters JR (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2(4):315–319CrossRefPubMed
20.
go back to reference Beskow LM, Dean E (2008) Informed consent for biorepositories: assessing prospective participants’ understanding and opinions. Cancer Epidemiol Biomark Prev A Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 17(6):1440–1451CrossRef Beskow LM, Dean E (2008) Informed consent for biorepositories: assessing prospective participants’ understanding and opinions. Cancer Epidemiol Biomark Prev A Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 17(6):1440–1451CrossRef
21.
go back to reference O’Doherty KC, Burgess MM (2009) Engaging the public on biobanks: outcomes of the BC biobank deliberation. Public Health Genomics 12(4):203–215CrossRefPubMed O’Doherty KC, Burgess MM (2009) Engaging the public on biobanks: outcomes of the BC biobank deliberation. Public Health Genomics 12(4):203–215CrossRefPubMed
Metadata
Title
Barriers and Strategies to Participation in Tissue Research Among African-American Men
Authors
Bettina F. Drake
Danielle Boyd
Kimberly Carter
Sarah Gehlert
Vetta Sanders Thompson
Publication date
01-03-2017
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 1/2017
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0905-1

Other articles of this Issue 1/2017

Journal of Cancer Education 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine